Joyce A. Boucheron

1.2k total citations
24 papers, 954 citations indexed

About

Joyce A. Boucheron is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Joyce A. Boucheron has authored 24 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Physiology. Recurrent topics in Joyce A. Boucheron's work include Carcinogens and Genotoxicity Assessment (11 papers), DNA Repair Mechanisms (4 papers) and Cancer-related gene regulation (4 papers). Joyce A. Boucheron is often cited by papers focused on Carcinogens and Genotoxicity Assessment (11 papers), DNA Repair Mechanisms (4 papers) and Cancer-related gene regulation (4 papers). Joyce A. Boucheron collaborates with scholars based in United States, Netherlands and France. Joyce A. Boucheron's co-authors include James A. Swenberg, Frank C. Richardson, N. Fedtke, Vernon E. Walker, Martin C. Dyroff, Scott H. Dickerson, Stephen A. Thomson, Margrith W. Verghese, Steven A. Belinsky and Frank Preugschat and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Environmental Health Perspectives.

In The Last Decade

Joyce A. Boucheron

23 papers receiving 923 citations

Peers

Countries citing papers authored by Joyce A. Boucheron

Since Specialization

Citations

This map shows the geographic impact of Joyce A. Boucheron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce A. Boucheron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce A. Boucheron more than expected).

Fields of papers citing papers by Joyce A. Boucheron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce A. Boucheron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce A. Boucheron. The network helps show where Joyce A. Boucheron may publish in the future.

Co-authorship network of co-authors of Joyce A. Boucheron

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce A. Boucheron. A scholar is included among the top collaborators of Joyce A. Boucheron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce A. Boucheron. Joyce A. Boucheron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes 2016 ·PLoS ONE ·Rebecca J. Hodge, Mark Paulik, Ann C. Walker, Joyce A. Boucheron, S. McMullen, (unknown), Derek J. Nunez	8
2	Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models 2015 ·PLoS ONE ·Deepak K. Rajpal, (unknown), David Mayhew, Joyce A. Boucheron, Aaron Spivak, Vinod Kumar, Karen Ingraham, Mark Paulik, Lihong Chen, Stephanie Van Horn, E. S. Thomas, Ganesh M. Sathe, George P. Livi, David Holmes, James R. Brown	40
3	Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Diane M. Ignar, Aaron S. Goetz, (unknown), (unknown), (unknown), (unknown), Joyce A. Boucheron, (unknown), (unknown), Andrea H. Epperly, Todd Shearer, Scott D. Sorensen, Jason D. Speake, Jonathan D. Hommel	41
4	Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Karen A. Evans, (unknown), Frank T. Coppo, Todd L. Graybill, (unknown), Mehul Patel, Jennifer Gale, Hu Li, Sara H. Thrall, David G. Tew, Francis X. Tavares, Stephen A. Thomson, James E. Weiel, Joyce A. Boucheron, (unknown), Andrea H. Epperly, Pamela L. Golden	9
5	Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy 2008 ·Bioorganic & Medicinal Chemistry Letters ·Stephen A. Thomson, (unknown), D. Mark Bickett, Joyce A. Boucheron, (unknown), (unknown), Joel P. Cooper, Scott H. Dickerson, Dulce Garrido, Robert T. Nolte, Andrew J. Peat, (unknown), Steven M. Sparks, Francis X. Tavares, Liping Wang, (unknown), James E. Weiel	16
6	Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3 2006 ·Bioorganic & Medicinal Chemistry Letters ·Terrence L. Smalley, Andrew J. Peat, Joyce A. Boucheron, Scott H. Dickerson, Dulce Garrido, Frank Preugschat, (unknown), Stephen A. Thomson, (unknown)	42
7	Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Andrew J. Peat, Joyce A. Boucheron, Scott H. Dickerson, Dulce Garrido, Wendy Y. Mills, (unknown), Frank Preugschat, Terrence L. Smalley, (unknown), (unknown), (unknown), Huiqiang Zhou, Stephen A. Thomson	58
8	Novel GSK-3 inhibitors with improved cellular activity 2004 ·Bioorganic & Medicinal Chemistry Letters ·Andrew J. Peat, Dulce Garrido, Joyce A. Boucheron, (unknown), Scott H. Dickerson, (unknown), (unknown), Stephen A. Thomson	46
9	Novel GSK‐3 Inhibitor with Improved Cellular Activity. 2004 ·ChemInform ·Andrew J. Peat, Dulce Garrido, Joyce A. Boucheron, (unknown), Scott H. Dickerson, (unknown), (unknown), Stephen A. Thomson	5
10	N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy 2004 ·Journal of Medicinal Chemistry ·Francis X. Tavares, Joyce A. Boucheron, Scott H. Dickerson, Robert Griffin, Frank Preugschat, Stephen A. Thomson, (unknown), Huiqiang Zhou	75
11	P2U Agonists Induce Chemotaxis and Actin Polymerization in Human Neutrophils and Differentiated HL60 Cells 1996 ·Journal of Biological Chemistry ·Margrith W. Verghese, (unknown), Joyce A. Boucheron	70
12	Vinyl chloride-induced DNA adducts II: Formating and persistence of 7-(2'oxoethyl)guanine and N² ,3 ethenoguanine in rat tissue DNA 1990 ·Carcinogenesis ·N. Fedtke, Joyce A. Boucheron, Vernon E. Walker, James A. Swenberg	87
13	Macromolecular adducts of ethylene oxide: a literature review and a time-course study on the formation of 7-(2-hydroxyethyl) guanine following exposures of rats by inhalation 1990 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Vernon E. Walker, Timothy R. Fennell, Joyce A. Boucheron, N. Fedtke, (unknown), (unknown)	48
14	Vinyl chloride-induced DNA adducts I: Quantitative determination of N²,3-ethenoguanine based on electrophore labeling 1990 ·Carcinogenesis ·N. Fedtke, Joyce A. Boucheron, Max J. Turner, James A. Swenberg	40
15	Hepatocyte initiation during continuous administration of diethylnitrosamine and 1,2-sym-dimethylhydrazine. 1988 ·PubMed ·Frank C. Richardson, Paul H. Morgan, Joyce A. Boucheron, (unknown), James A. Swenberg	15
16	Molecular dosimetry of O4-ethyldeoxythymidine in rats continuously exposed to diethylnitrosamine. 1987 ·PubMed ·Joyce A. Boucheron, Frank C. Richardson, Paul H. Morgan, James A. Swenberg	42
17	High- to low-dose extrapolation: critical determinants involved in the dose response of carcinogenic substances. 1987 ·Environmental Health Perspectives ·James A. Swenberg, Frank C. Richardson, Joyce A. Boucheron, (unknown), Steven A. Belinsky, Michel Charbonneau, Brian Short	59
18	Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. 1986 ·PubMed ·Steven A. Belinsky, Catherine M. White, Joyce A. Boucheron, Frank C. Richardson, James A. Swenberg, Marshall W. Anderson	86
19	Biochemical and morphologic studies of heterogeneous lobe responses in hepatocarcinogenesis 1986 ·Carcinogenesis ·Frank C. Richardson, Joyce A. Boucheron, Martin C. Dyroff, James A. Popp, James A. Swenberg	39
20	Relationships between DNA adduct formation and carcinogenesis. 1985 ·Environmental Health Perspectives ·(unknown), Frank C. Richardson, Joyce A. Boucheron, Martin C. Dyroff	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact